StockDrifts LogoStockDrifts

biodyne 314930

Company
바이오다인biodyne
Insiders
3
Buys
18
Total Value
₩3.9B ($2.7M)
Avg Return
+0.23%
Last Filing
2026-07-10

biodyne (314930) has 18 disclosed insider purchases and 1 disclosed disposals on record, filed by 3 distinct insiders. Together those filings cover ₩3.9B ($2.7M) in reported transaction value. The earliest filing StockDrifts holds for biodyne is dated 2024-02-28; the most recent is 2026-07-10. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea). Across these filings the average return since disclosure is +0.23%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2026-07-10BUYMarket Buy
양근호
Yang Geun-ho
Internal director2.0K₩8,580-2.6%₩17M ($12K)
2026-07-09BUYMarket Buy
양근호
Yang Geun-ho
Internal director1.0K₩8,580-2.6%₩9M ($6K)
2026-07-03BUYMarket Buy
임욱빈
Wookbin Lim
CEO19.6K₩9,480-9.5%₩186M ($129K)
2026-06-04BUYMarket Buy
임욱빈
Wookbin Lim
CEO10.0K₩10,020-2.6%₩101M ($70K)
2026-06-02BUYMarket Buy
임욱빈
Wookbin Lim
CEO13.0K₩9,710+0.5%₩126M ($88K)
2026-06-01BUYMarket Buy
임욱빈
Wookbin Lim
CEO14.8K₩9,710+0.5%₩143M ($100K)
2026-05-29BUYMarket Buy
임욱빈
Wookbin Lim
CEO11.8K₩10,000-2.4%₩118M ($82K)
2026-05-28BUYMarket Buy
임욱빈
Wookbin Lim
CEO13.0K₩10,480-6.9%₩136M ($95K)
2026-05-27BUYMarket Buy
임욱빈
Wookbin Lim
CEO14.9K₩10,320-5.4%₩154M ($107K)
2025-11-26BUYMarket Buy
양근호
Yang Geun-ho
Internal director1.4K₩13,290+5.7%₩19M ($13K)
2025-11-24BUYMarket Buy
양근호
Yang Geun-ho
Internal director650₩13,350+5.2%₩9M ($6K)
2025-11-22BUYMarket Buy
양근호
Yang Geun-ho
Internal director177₩13,350+5.2%₩2M ($2K)
2025-11-21BUYMarket Buy
양근호
Yang Geun-ho
Internal director923₩13,810+1.7%₩13M ($9K)
2025-11-20BUYMarket Buy
양근호
Yang Geun-ho
Internal director2.6K₩13,770+2.0%₩36M ($25K)
2025-11-20BUYMarket Buy
고유라
Go Yoo-ra
Internal director1.0K₩13,770+2.0%₩14M ($10K)
2025-08-08SELL시간외매매
임욱빈
Wookbin Lim
CEO-1.2M₩15,880+11.5%₩18.4B ($12.8M)
2024-09-10BUYMarket Buy
고유라
Go Yoo-ra
Internal director660₩13,330+5.4%₩9M ($6K)
2024-09-09BUYMarket Buy
고유라
Go Yoo-ra
Internal director340₩13,490+4.2%₩5M ($3K)
2024-09-09BUYMarket Buy
양근호
Yang Geun-ho
Internal director1.0K₩13,490+4.2%₩13M ($9K)
2024-03-26BUY신규보고
고유라
Go Yoo-ra
Internal director1.9K₩9,310+50.9%₩17M ($12K)
2024-03-26BUY신규보고
양근호
Yang Geun-ho
Internal director8.2K₩9,310+50.9%₩76M ($53K)
2024-02-29BUY무상신주취득
조우석
Jo Woo-seok
CL168.8K₩11,890+18.2%₩2.0B ($1.4M)
2024-02-29BUY무상신주취득
임욱빈
Wookbin Lim
CEO10.7M₩11,890+18.2%₩127.3B ($88.4M)
2024-02-28SELLMarket Sell
임욱빈
Wookbin Lim
CEO-200.3K₩13,980-0.5%₩2.8B ($1.9M)

Frequently asked questions

Who has been buying biodyne stock?
3 distinct insiders have filed 18 disclosed insider purchases in biodyne (314930), most recently on 2026-07-10. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does biodyne have?
biodyne has 18 buy-side and 1 sell-side disclosures on record, covering ₩3.9B ($2.7M) in total reported value, spanning 2024-02-28 to 2026-07-10.
Where does StockDrifts get biodyne insider data?
From DART D001/D002 insider disclosures — the official filing system run by the Financial Supervisory Service (Korea). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from DART.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean DART filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Source filings

Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for biodyne. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.